It would be hard to imagine improving on the intelligence of computer engineer Bjoern Stenger, a doctoral candidate at Cambridge University. Yet for several hours, a pill seemed to make him even brainier.
Participating in a research project, Stenger downed a green gelatin cap containing a drug called modafinil. Within an hour, his attention sharpened. So did his memory. He aced a series of mental-agility tests. If his brainpower would normally rate a 10, the drug raised it to 15, he said.
For The Record
Los Angeles Times Tuesday December 21, 2004 Home Edition Main News Part A Page 2 National Desk 1 inches; 45 words Type of Material: Correction
Brain-boosting drugs -- An article on drugs that enhance mental performance in Monday's Health section said James L. McGaugh was director of the Center for the Neurobiology of Learning and Memory at UC Irvine. He is the former director. Dr. Michael Rugg is the director.
For The Record
Los Angeles Times Monday December 27, 2004 Home Edition Health Part F Page 4 Features Desk 1 inches; 47 words Type of Material: Correction
Brain-boosting drugs -- An article on drugs that enhance mental performance in the Dec. 20 Health section said James L. McGaugh was director of the Center for the Neurobiology of Learning and Memory at UC Irvine. He is the former director. Dr. Michael Rugg is the director.
"I was quite focused," said Stenger. "It was also kind of fun."
The age of smart drugs is dawning. Modafinil is just one in an array of brain-boosting medications -- some already on pharmacy shelves and others in development -- that promise an era of sharper thinking through chemistry.
These drugs may change the way we think. And by doing so, they may change who we are.
Long-haul truckers and Air Force pilots have long popped amphetamines to ward off drowsiness. Generations of college students have swallowed over-the-counter caffeine tablets to get through all-nighters. But such stimulants provide only a temporary edge, and their effect is broad and blunt -- they boost the brain by juicing the entire nervous system.
The new mind-enhancing drugs, in contrast, hold the potential for more powerful, more targeted and more lasting improvements in mental acuity. Some of the most promising have reached the stage of testing in human subjects and could become available in the next decade, brain scientists say.
"It's not a question of 'if' anymore. It's just a matter of time," said geneticist Tim Tully, a researcher at Cold Spring Harbor Laboratory on Long Island, N.Y., and developer of a compound called HT-0712, which has shown promise as a memory enhancer. The drug soon will be tested in human subjects.
The new brain boosters stem in part from research to develop treatments for Alzheimer's disease, spinal cord injuries, schizophrenia and other conditions. But they also reflect rapid advances in understanding the processes of learning and memory in healthy people.
In the last two decades, scientists have made important discoveries about which regions of the brain perform specific functions and how those regions work together to absorb, store and retrieve information. Researchers also have begun to grasp how and where neurotransmitters are manufactured and which ones help perform which mental tasks.
"There are things cooking here that couldn't have been done one to two decades ago," said James L. McGaugh, director of UC Irvine's Center for the Neurobiology of Learning and Memory.
Research has gotten further stimulus from a deep-pocketed investor -- the U.S. military, which is looking for ways to help pilots and soldiers stay sharp under the stress and exhaustion of combat.
The potential market for cognitive enhancers has never been bigger, or more receptive.
An estimated 77 million members of the baby boom generation will turn 50 in the next 10 years, joining 11 million who have already passed the half-century mark -- a stage at which memory and speed of response show noticeable decline.
Modafinil, the drug that whetted Stenger's powers of concentration, is used to treat narcolepsy and other sleep disorders. It is one of three prescription medications on the market that have been shown to enhance certain mental powers.
The other two are methylphenidate, marketed under the name Ritalin as a remedy for attention deficit disorder, and donepezil, prescribed for patients with Alzheimer's.
Studies have shown that these drugs can produce significant mental gains in normal, healthy subjects. None of the three has been approved for that purpose. Nevertheless, a growing number of healthy Americans are taking them to get a mental edge.
Some obtain the medications from doctors who write prescriptions for "off-label" uses not approved by the Food and Drug Administration -- a practice both legal and common. Others buy the drugs through unregulated Internet pharmacies.
Cambridge University psychologist Barbara Sahakian considers modafinil (marketed commercially under the name Provigil) especially intriguing. Its developers aren't sure exactly how it keeps drowsiness at bay. But even in healthy people, the medication appears to deliver measurable improvements with few side effects.
In a series of experiments in 2001, Sahakian and colleagues found that in games that test mental skill, subjects who took a 200-milligram dose of modafinil paid closer attention and used information more effectively than subjects given a sugar pill.
Confronted with conflicting demands, the people on modafinil moved more smoothly from one task to the next and adjusted their strategies of play with greater agility. In short, they worked smarter and were better at multi-tasking.
"In my mind, it may be the first real smart drug," Sahakian said. "A lot of people will probably take modafinil. I suspect they do already."